海尔生物：累计回购公司股份1845488股

Group 1 - The core point of the article is that Haier Biomedical announced a share buyback plan, indicating a strategic move to enhance shareholder value [1] - As of July 31, 2025, the company has repurchased a total of 1,845,488 shares [1] - This repurchase represents 0.5804% of the company's total share capital, which is 317,952,508 shares [1]